[The efficacy and safety of tocilizumab combined with disease-modifying anti-rheumatoid drugs in the treatment of active rheumatoid arthritis: a multi-center, randomized, double-blinded, placebo-controlled trial].
Qun Shi, Yan Zhao, Xing-Fu Li, Feng Huang et autres
5 citationsPubMed